The results of our experiments demonstrated that TET1 plays a role in promoting EMT in CCA cells by activating CLDN3 transcription by targeting the CLDN3 promoter region from −16 to 512 for demethylation. Here, CLDN3 is linked to cholangiocarcinoma.